<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="154690">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01874691</url>
  </required_header>
  <id_info>
    <org_study_id>2011BAI11B02-A</org_study_id>
    <secondary_id>2011BAI11B02</secondary_id>
    <nct_id>NCT01874691</nct_id>
  </id_info>
  <brief_title>China Acute Myocardial Infarction Registry</brief_title>
  <acronym>CAMIRegistry</acronym>
  <official_title>China Acute Myocardial Infarction Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cardiovascular Institute &amp; Fuwai Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cardiovascular Institute &amp; Fuwai Hospital</source>
  <oversight_info>
    <authority>China: Ministry of Science and Technology</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to build a Chinese national registry and surveillance system for acute
      myocardial infarction(AMI) to obtain real-world information about current status of
      characteristics, risk factors, diagnosis, treatment and outcomes of Chinese AMI patients;
      And to propose scientific precaution strategies aimed to prevent effectively from the
      incidence of AMI; And to optimize the management and outcomes of AMI patients through
      implementation of guideline recommendations in clinical practice, and analysis and
      development of effective treatment strategies; And to create cost-effective assessment
      system.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study is to establish the national platform for surveillance, clinical
      research and translational medicine in China, designed to facilitate efforts to improve the
      quality of AMI patient care and thus decrease morbidity and mortality associated with AMI.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>In-hospital mortality of the patients with acute myocardial infarction in different-level hospitals across China</measure>
    <time_frame>the duration of hospital stay, an expected average of  2 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Different-level hospitals include Provincial-level, city-level, County-level hospitals from all over China.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The rate of the application of thrombolysis and primary percutaneous coronary intervention for Chinese patients with acute myocardial infarction in different-level hospitals</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>In different-level hospitals, How many patients with acute myocardial infarction receive thrombolysis and/or primary percutaneous coronary intervention within 24 hours from the onset,respectively?</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>provoking factors of Chinese patients with AMI across different areas and different population in China</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>The different factors that can provoke the onset of acute myocardial infarction, for example, excess exercise, overload work, heavy smoking, heavy drinking of alcohol and so on.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>the in-hospital cost of Chinese patients with acute myocardial infarction</measure>
    <time_frame>the duration of hospital stay, an expected average of  2 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20000</enrollment>
  <condition>Acute Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>acute myocardial infarction</arm_group_label>
    <description>acute myocardial infarction including ST-elevation and non ST-elevation myocardial infarction</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Eligible patients admitted within 7 days of acute ischemic symptoms and diagnosed acute
        ST-elevation or non ST-elevation myocardial infarction.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Eligible patients must be admitted within 7 days of acute ischemic symptoms and
             diagnosed acute ST-elevation or non ST-elevation myocardial infarction. Diagnosis
             criteria must meet Universal Definition for AMI (2012). All participating hospitals
             are required to enroll consecutive patients with AMI.

        Exclusion Criteria:

          -  Myocardial infarction related to percutaneous coronary intervention and coronary
             artery bypass grafting.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yuejin Yang, MD.</last_name>
    <role>Study Chair</role>
    <affiliation>Fuwai Hospital, Chinse Academy of Medical Sciences</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yuejin Yang, MD</last_name>
    <phone>+8610-88398760</phone>
    <email>yangyjfw@yahoo.com.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Haiyan Xu, MD.</last_name>
    <phone>+88396790</phone>
    <email>ami125@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Fuwai Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100037</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Haiyan Xu, MD.</last_name>
      <phone>+8610-88396790</phone>
      <email>ami125@126.com</email>
    </contact>
    <contact_backup>
      <last_name>Qiuting Dong, MD.</last_name>
      <phone>+88396151</phone>
      <email>blue1005dqt@163.com</email>
    </contact_backup>
    <investigator>
      <last_name>Yuan Wu, MD.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lei Song, MD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>http://www.camiregistry.org</url>
    <description>China AMI registry</description>
  </link>
  <reference>
    <citation>Peterson ED, Roe MT, Rumsfeld JS, Shaw RE, Brindis RG, Fonarow GC, Cannon CP. A call to ACTION (acute coronary treatment and intervention outcomes network): a national effort to promote timely clinical feedback and support continuous quality improvement for acute myocardial infarction. Circ Cardiovasc Qual Outcomes. 2009 Sep;2(5):491-9. doi: 10.1161/CIRCOUTCOMES.108.847145.</citation>
    <PMID>20031882</PMID>
  </reference>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 7, 2013</lastchanged_date>
  <firstreceived_date>June 4, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cardiovascular Institute &amp; Fuwai Hospital</investigator_affiliation>
    <investigator_full_name>Yang yuejin</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <keyword>acute myocardial infarction</keyword>
  <keyword>China</keyword>
  <keyword>Registry</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
